Karimah Es Sabar sold $3.5M of Capricor Therapeutics (CAPR)

Executed Mar 31, disclosed Apr 1, 1 day later.

Value, as filed

$3.5M

115,000 sh across 2 lots

Executed

Mar 31

the trade date, as filed

Disclosed

Apr 1

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Karimah Es Sabar Director profile →

Karimah Es Sabar (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Capricor Therapeutics, Inc. (CAPR). The largest single filing was $3.5M of CAPR (115,000 sh across 2 lots, as filed), executed Mar 31.

The name

CAPR

Capricor Therapeutics, Inc. CAPR · Healthcare · 9 filings in 24 months ticker →

Healthcare · Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Karimah Es Sabar in CAPR

CAPRSALE Capricor Therapeutics, Inc. $241K
7,529 sh × $32.00
Exec Apr 2
Filed Apr 3 · 5:30 PM ET